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Evidence of two distinct functionally
specialized fibroblast lineages in breast
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Ole William Petersen1,2 and Lone Rønnov-Jessen3*
Abstract
Background: The terminal duct lobular unit (TDLU) is the most dynamic structure in the human breast and the
putative site of origin of human breast cancer. Although stromal cells contribute to a specialized microenvironment
in many organs, this component remains largely understudied in the human breast. We here demonstrate the
impact on epithelium of two lineages of breast stromal fibroblasts, one of which accumulates in the TDLU while
the other resides outside the TDLU in the interlobular stroma.
Methods: The two lineages are prospectively isolated by fluorescence activated cell sorting (FACS) based on
different expression levels of CD105 and CD26. The characteristics of the two fibroblast lineages are assessed by
immunocytochemical staining and gene expression analysis. The differentiation capacity of the two fibroblast
populations is determined by exposure to specific differentiating conditions followed by analysis of adipogenic and
osteogenic differentiation. To test whether the two fibroblast lineages are functionally imprinted by their site of
origin, single cell sorted CD271low/MUC1high normal breast luminal epithelial cells are plated on fibroblast feeders
for the observation of morphological development. Epithelial structure formation and polarization is shown by
immunofluorescence and digitalized quantification of immunoperoxidase-stained cultures.
Results: Lobular fibroblasts are CD105high/CD26low while interlobular fibroblasts are CD105low/CD26high. Once
isolated the two lineages remain phenotypically stable and functionally distinct in culture. Lobular fibroblasts have
properties in common with bone marrow derived mesenchymal stem cells and they specifically convey growth
and branching morphogenesis of epithelial progenitors.
Conclusions: Two distinct functionally specialized fibroblast lineages exist in the normal human breast, of which
the lobular fibroblasts have properties in common with mesenchymal stem cells and support epithelial growth and
morphogenesis. We propose that lobular fibroblasts constitute a specialized microenvironment for human breast
luminal epithelial progenitors, i.e. the putative precursors of breast cancer.
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Background
Development of glandular organs such as the breast in-
volves the process of branching morphogenesis, which is
the result of an interaction between the epithelium and
the surrounding mesenchyme [1]. Unlike most parenchy-
mal epithelial cells, in general mesenchymal stromal cells
have not been classified into particular lineages or consid-
ered participants of tissue specific stem cell hierarchies.
However, evidence is accumulating that epithelial stem or
progenitor competence is linked to proximity to special-
ized fibroblasts [2]. It is well-established that the human
breast is characterized by the presence of two anatomically
distinct types of stroma, a relatively less cellular, fibrous
stroma embedding the interlobular ducts and a more cel-
lular, loosely arranged stroma embedding the terminal
ductules, in toto referred to as the TDLU [3, 4]. Under
resting, homeostasis conditions the vast majority of
cellular turnover takes place in TDLUs and is fuelled by
cycling cells within the luminal epithelial lineage [5]. As
the majority of breast cancer is also luminal and originates
in TDLUs, the question of whether the stromal micro-
environment contributes to cellular turnover in this com-
partment deserves some attention. As described here, our
efforts to address this have led to the discovery of
CD105high/CD26low lobular fibroblasts which compared to
CD105low/CD26high interlobular fibroblasts resemble mes-
enchymal stem cells and support luminal epithelial growth
and branching morphogenesis.
Methods
Tissue
Normal breast biopsies of which some were included in
previous work [6] were collected with consent from
women undergoing reduction mammoplasty for cos-
metic reasons. The use and storage of human material
has been approved by the Regional Scientific Ethical
Committees (Region Hovedstaden, H-2-2011-052) and
the Danish Data Protection Agency (2011-41-6722).
Tissue samples for immunohistochemical staining were
kept at −80 °C and epithelial organoids and fibroblasts
were isolated as described [6, 7].
Cell culture
Fibroblasts were plated in Primaria™ T-25 flasks (Becton
Dickenson) [7] in DMEM/F-12 (DMEM:Ham’s F12
Nutrient Mixture (F12), 1:1 v/v, Life Technologies), with
2 mM glutamine and 1 % fetal bovine serum (FBS,
Sigma). The cultures were split at a 1:3 ratio and
expanded until the fourth to the fifth passage in
collagen-coated flasks (Nunc, 8 μg collagen/cm2, Pure-
Coll, CellSystems) in basal medium with 5 % FBS prior
to fluorescence activated cell sorting (FACS). Sorted fi-
broblasts were sub-cultured under the same conditions.
Profiling of fibroblasts in the second and third passages
from two biopsies, which had undergone limited, if any,
proliferation [7] (plated on Primaria™ with 1 % FBS and
switched to 5 % FBS upon passage) were included to en-
sure that the observed phenotypes represented primary
cells. For comparison with breast fibroblasts a human
telomerase, reverse transcriptase-immortalized, human
mesenchymal stem cell (hMSC) line was employed [8].
Flow cytometric analysis and FACS
Epithelial organoids or fibroblasts derived from a total of
13 biopsies were prepared for FACS as described [6]. To
isolate CD271 (nerve growth factor receptor)low/mucin 1
(MUC1)high, luminal epithelial cells, suspended cells from
organoids were incubated for 30 minutes at 4 °C in the
presence of CD271-APC (ME20.4, 1:50, Cedarlane
Laboratories) and MUC1 (115D8, 1:50, Monosan)
followed by AF488 (IgG2b, 1:500, Life Technologies).
Fibroblasts were incubated with CD105-AF488 (SN6,
1:25, AbD Serotec) and CD26 (202–36, 1:200, Abcam),
followed by AF647 (IgG2b, 1:500). Controls were without
primary antibody. 1 μg/ml propidium iodide (Invitrogen)
or Fixable Viability Stain 780 (1:1000, BD Biosciences) was
added 10 minutes prior to analysis and sorting (FACSAria
I and II; BD Biosciences).
Assessment of proliferation
CD105 (endoglin)high/CD26 (dipeptidyl peptidase-4)low
and CD105low/CD26high cultures were split weekly at
5600 cells/cm2 and the number of population doublings
were calculated as:
n ¼ 3:32 Log UCY ‐ Log Ið Þ þ X
in which n = population doubling, UCY = cell yield, I = in-
oculum number, X = population doubling of inoculum).
Triplicate cultures seeded at 2770 cells/cm2 in passage
9 were used to quantify cell culture dynamics. Triplicate
cultures representing three different biopsies were used
to determine the endpoint number. Cells were counted
manually using a Burker-Türk chamber.
Co-culture
CD271low/MUC1high primary luminal epithelial cells
were seeded at 6000 cells/cm2 on confluent fibroblast
feeders of CD105high/CD26low and CD105low/CD26high
cells, respectively, in modified breastoid base medium
without HEPES [9] (DMEM/F-12, 1:1), 1 μg/ml hydrocor-
tisone (Sigma-Aldrich), 9 μg/ml insulin (Sigma-Aldrich),
5 μg/ml transferrin (Sigma-Aldrich), 5.2 ng/ml Na-
Selenite (BD Industries), 100 μM ethanolamine (Sigma-
Aldrich), 20 ng/ml basic fibroblast growth factor
(PeproTech), 5 nM amphiregulin (R&D Systems), with the
addition of 10 μM Y-27632 (Axon Medchem), 1.8 × 10−4
M adenine (Sigma Aldrich) and the serum replacement
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B27 (20 μl/ml, Life Technologies) [6]. hMSC feeders cul-
tured under similar conditions were used for comparison.
To determine whether luminal progenitors and differ-
entiated cells responded differently to co-culture, FACS-
sorted CD166 (ALCAM)high/laminin receptor 67LRhigh
(EpCAMhigh/CD166high/LNR67high) or CD166high (EpCAM-
high/CD90low/CD166high) differentiated luminal cells versus
67LRlow (EpCAMhigh/CD166low/LNR67low) or CD166low
(EpCAMhigh/CD90low/CD166low) progenitors [6] were con-
fronted with either CD105high/CD26low or CD105low/
CD26high cells under similar conditions. Epithelial structure
formation was observed for up to three weeks by phase con-
trast microscopy and photographed (Leica DM IL).
Immunostaining
Cryostat sections (6–8 μm) and cultures were stained by
immunoperoxidase essentially as described, including in-
cubation without primary antibody as control [5, 10, 11],
for CD26 (1:50), CD105 (SN6, 1:200, Abcam) or MUC1
(1:100). Staining was photographed with the Leica
DM5500B. For fluorescence staining, cryostat sections
were incubated with CD26 (1:50) and CD105 (1:100) for
60 minutes, and AF568 (IgG2b, 1:500) and AF488 (IgG1,
1:500) for 30 minutes. Co-cultures were stained for
fluorescence with MUC1 (1:10), K19 (Ba16, 1:50,
Abcam) and K14 (LL002, 1:25, Abcam) followed by
AF568 (IgG1, 1:500) and AF488 (IgG2b or IgG3, 1:500).
Smooth muscle differentiation was detected by double
staining for α-smooth muscle actin (1A4, 1:1000, Sigma)
and CD105 (SN6, 1:50) followed by AF568 (IgG2a,
1:500) and AF488 (IgG1, 1:500). Fluorescence staining
was evaluated and photographed using confocal micros-
copy (Zeiss LSM 700).
Images of co-cultures immunoperoxidase-stained for
K19 (1:200) were acquired on a Leica Z6 AP0 at 1.25
magnification. A minimum of 2.2 cm2 was imaged and
quantified (ImageJ, version 1.49 t). All images were ana-
lyzed in batch using a macro. Briefly, images were con-
verted to 8-bit and duplicated. While one image was
inverted and 160 was subtracted from it, the Differen-
tials plugin [12] and the Laplacian operation was applied
to the other followed by re-conversion to 8-bit. The two
images were combined by multiplication and binarized
by the Make Binary plugin. Images were analyzed by the
Analyze Particles command using a lower size threshold
of 0.0026 mm2 and excluding structures touching the
image edge. Data were exported to Excel for plotting
and handling.
Microarray analysis
Total RNA was isolated in triplicate from CD105high/
CD26low and CD105low/CD26high cells in passage 9 using
the GenElute Mammalian Total RNA Miniprep Kit
(Sigma-Aldrich): 100 ng RNA was labeled using the
Ambion® WT Expression Kit (Ambion), and hybridized
to the Affymetrix GeneChip®Human Gene 2.0 ST Array
(Affymetrix) for 16 hours at 45 °C at 60 rpm and
scanned with The GeneChip Scanner 3000 7G (Affyme-
trix). Data were imported into the GeneSpring GX 13.0
software and quantile-normalized with the RMA16 algo-
rithm. For variance stabilization 16 was added before
log2 transformation. Transcripts were annotated with
netaffx annotation build 34. Statistical analyses of gene ex-
pression data were performed using the unpaired t test with
Benjamini and Hochberg false discovery rate (FDR) p value
correction. A total of 302 genes were considered signifi-
cantly differentially expressed by a statistical significance
threshold (corrected p < 0.05) and fold change larger than
two. From these, 44 were selected for heat map presenta-
tion. A possible overlap among the 302 differentially
expressed genes with previously published profiles of breast
tumor versus normal stroma was analyzed using Oncomi-
ne.org., and tested for significance by Fisher’s exact test if
common between at least two out of three studies [13–15].
Analysis of differentiation potential
For adipogenic differentiation fibroblasts were seeded
overnight at 40,000 cells/cm2 in 6-well plates (Nunc),
and changed to adipogenic induction medium (AIM)
[16]. Adipogenic induction was visualized by Oil Red O
staining at day 15. Cultures were fixed for 10 minutes in
4 % paraformaldehyde, rinsed in 3 % isopropanol and
stained with Oil Red O (Sigma-Aldrich, 25 mg Oil Red
O dye, 5 ml 100 % isopropanol and 3.35 ml water) for
one hour at room temperature. For osteogenic differenti-
ation, fibroblasts were seeded overnight at 20,000 cells/
cm2, and changed to osteoblastic induction medium
(OIM) [16]. Controls were exposed to minimal essential
medium (MEM, Invitrogen) with 10 % FBS.
For early osteogenic differentiation, alkaline phosphatase
activity was measured and normalized to cell viability as
described [17]. Alizarin Red staining was used to assess in
vitro formation of mineralized matrix at day 15 after
osteogenic induction as described [16]. Controls were ex-
posed to MEM with 10 % FBS. Induction of differentiation
in hMSCs was used as positive control in all assays.
Smooth muscle differentiation of CD105high/CD26low
cells was demonstrated by plating in passage 17 at a
density of 4000 cells/cm2 on PrimariaTM in DMEM:F12
with glutamine followed by starvation for two days prior
to exposure to 20 % serum for four days. High serum
concentration has previously been shown to enhance α-
smooth muscle actin in breast fibroblasts [18].
RNA extraction and real-time quantitative polymerase
chain reaction (RT-qPCR)
For analysis of gene expression levels of osteogenic and
adipogenic markers in induced and non-induced cultures,
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total RNA was extracted using TRIzol and first strand
cDNA was prepared by the revertAid H minus first-strand
cDNA synthesis kit (Fermentas, St. Leon-Rot, Germany).
RT-qPCR was performed using the StepOnePlus qPCR
system and FAST SYBR Green master mix. Gene expres-
sion levels were determined using the formula 1/2ΔCT, in
which ΔCT represents the difference between the target
and the geometric mean of reference genes. Adhering to
the guidelines for minimum information for publication
of RT-qPCR experiments [19], we employed two reference
genes for normalization: Beta-2-microglobulin (β2m) and
ubiquitin C (UBC). Primers used are listed in Table 1.
To validate microarray results, RT-qPCR of 22 represen-
tative transcripts was performed in triplicate and further
confirmed using RNA extracted from cells in passage 11
derived from another biopsy. Total RNA was reverse-
transcribed using the High Capacity RNA-to-cDNA Kit
(Applied Biosystems). RT-qPCR was performed as
described [6] using TaqMan Gene Expression Assays
(Applied Biosystems) and primers listed in Table 2.
Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH),
Transferrin receptor (TFRC), hypoxanthine phosphoribo-
syltransferase 1 (HPRT1) and phosphoglycerate kinase 1
(PGK1) served as reference genes for normalization and
gene expression levels were calculated by the formula 1/
2ΔCT.
Results
We and others have reported a stem cell zone in TDLUs of
the human breast [5, 20]. To identify possible juxtaepithelial
cells responsible for growth of luminal progenitors in TDLU
we screened our antibody library with respect to relevant
topographical fibroblast heterogeneity. Two surface markers,
CD105 and CD26, consistently exhibited a non-overlapping
staining pattern, one of which, CD26, has previously been
shown to distinguish intralobular and interlobular breast
stroma [21, 22]. In all specimens containing lobules (14 out
of 17 biopsies), CD105, aside from staining the microvascu-
lature, primarily stained stromal cells delineating acini, while
CD26 was consistently present in the interlobular stroma
albeit with varying intensity and in some instances (2 out of
17 biopsies) primarily surrounding interlobular ducts. In
general, CD26-positive cells were completely absent from
intralobular stroma except for occasional cells surrounding
intralobular terminal ducts (Fig. 1a).
In spite of some variance in FACS pattern among
biopsies, CD105high/CD26low and CD105low/CD26high
cells could be readily purified from 5/5 biopsies (Fig. 1b)
into cell strains that could be propagated for more than
20 population doublings (Fig. 1c). The two phenotypes
could be distinguished by immunocytochemical staining
in primary culture, but to increase yield, fibroblasts were
expanded prior to cell sorting. The two cell populations
were inherently different with respect to growth rate;
CD105high/CD26low cells consistently growing slower
than CD105low/CD26high cells (Fig. 2a and b). The
CD105high/low phenotype was maintained with passage,
while a differential expression of CD26 remained in 3/5
biopsies (Fig. 2c). Thus, we found CD105 to be a more re-
liable marker for distinguishing the two phenotypes. The
cell strains could easily be passaged beyond passage 15.
To investigate the characteristics of the two cell lineages
in more detail, a microarray analysis was performed
(Fig. 3a) and the observed differences were validated by
RT-qPCR (Additional file 1: Figure S1) and confirmed in
another biopsy. The molecular signature revealed that the
profile of CD105high/CD26low cells included induction of
myofibroblast-related characteristics i.e. genes regulated
by transforming growth factor-beta 1, such as ACTA2,
COLL, TNC and FNDC1 as compared to an immune-
system-related signature, including complement factors,
Table 1 Primers for RT-qPCR analysis
Gene symbol Forward primer Reverse primer
CEBPA AAC CTT GTG CCT TGG AAA TG CTG TAG CCT CGG GAA GGA G
Col1a1 AGG GCT CCA ACG AGA TCG AGA TCC G TAC AGG AAG CAG ACA GGG CCA ACG TCG
Runx2 TCT TCA CAA ATC CTC CCC TGG ATT AAA AGG ACT TGG
β2m CCT TGA GGC TAT CCA GCG T CCT GCT CAG ATA CAT CAA ACA TG
UBC ATT TGG GTC GCG GTT CTT G TGC CTT GAC ATT CTC GAT GGT
Table 2 TaqMan primers for microarray confirmation
Gene symbol Assay ID Gene symbol Assay ID
ENG (CD105) Hs00923996_m1 SCUBE3 Hs00738371_m1
HGF Hs00300159_m1 FNDC1 Hs00287359_m1
CFB Hs00156060_m1 DPT Hs00355056_m1
C3 Hs00163811_m1 GDF6 Hs01377663_m1
IL33 Hs00369211_m1 ACVRL1 Hs00953798_m1
COL4A1 Hs00266237_m1 ACVR2A Hs00155658_m1
TNC Hs01115665_m1 ACTA2 Hs00426835_g1
COL15A1 s00266332_m1 LAMA2 Hs01124081_m1
CNN1 Hs00154543_m1 TSPAN2 Hs00194836_m1
GPRC5B Hs00212116_m1 HPRT1 Hs99999909_m1
IL1RL1 Hs00249384_m1 GAPDH Hs02758991_g1
DCN Hs00370384_m1 PGK1 Hs00943178_g1
COL11A1 Hs01097664_m1 TFRC Hs00951083_m1
Morsing et al. Breast Cancer Research  (2016) 18:108 Page 4 of 11
SCL39A8 [23], IL33/IL1RL1 [24], IL1R1 [25] and IL18R1
[26] in the CD105low/CD26high cells (Fig. 3a). Differential
expression of COL14A1/undulin is in accordance with
findings by others [27].
The similarity between CD105high/CD26low cells and
myofibroblasts, including possible co-expression of
CD105 and alpha-smooth muscle actin (Additional file 2:
Figure S2), was further supported by comparison with pre-
vious datasets of differentially expressed genes in breast
tumor versus normal stroma [13–15]. Thus, among genes
differentially expressed between normal breast and breast
cancer, the majority of genes in common with the present
profiles were identified between CD105high cells and
tumor stroma (p < 0.001, Fig. 3b). The overlap between
genes expressed by CD105high cells and tumor stroma
included Wingless-type MMTV integration site family
member 5A (WNT5A), Vitamin D (1,25- dihydroxyvita-
min D3) receptor (VDR), Sulfatase 2 (SULF2), Sushi repeat
containing protein x-linked 2 (SRPX2), Secreted frizzled-
related protein 2 (SFRP2), Phospholipid phosphatase 4
(PLPP4), NADPH oxidase 4 (NOX4), Leucine rich repeat-
ing containing 15 (LRRC15), Lim and cysteine rich
domains 1 (LMCD1), Interferon gamma-inducible protein
30 (IFI30), Growth arrest and DNA-damage inducible beta
(GADD45B), Fibronectin type III domain containing 1
(FNDC1), Fc Fragment of IgE receptor Ig (FCER1G),
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Fig. 1 Characterization, isolation and cultivation of interlobular and intralobular fibroblasts. a Multicolor imaging of cryostat sections of normal breast
tissue showing an interlobular duct (left) and a terminal duct lobular unit (TDLU, right) stained for CD105 (green), CD26 (red) and nuclei (blue). An
intralobular terminal duct (ITD) connects the TDLU to the interlobular duct. Phenotypically distinct fibroblasts surround the two anatomical structures.
b Fluorescence activated cell sorting diagram of serially passaged fibroblasts stained with CD26 and CD105. Circles indicate gates selected for sorting. c
Time course of population doublings of CD26high (light squares) and CD105high (dark squares) fibroblasts in serial passage subculture (scale bar= 50 μm)
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Cartilage oligomeric matrix protein (COMP), Collagen
type XI alpha 1 (COL11A1), Collagen type X alpha 1
(COL10A1), and Asporin (ASPN).
As CD105 has been identified as a marker of MSCs [28],
we determined the differentiation capacity of the two popu-
lations as compared to hMSCs. Only the CD105high/
CD26low cells resembled hMSCs by the potential to differen-
tiate along adipogenic and osteogenic lineages (Fig. 3c and d
and Additional file 3: Figure S3), and this difference in re-
sponse was maintained up to passage 15 (Additional file 3:
Figure S3).
To test whether stromal cells are functionally
imprinted by their site of origin, we next investigated the
association between luminal breast epithelial growth and
the CD105/CD26 lineages. Seeding of single cell
CD271low/MUC1high luminal epithelial cells (Additional
file 4: Figure S4) on fibroblast feeders resulted in the for-
mation of tubular structures with a central lumen within
three weeks (Fig. 4a). Staining with epithelial lineage
markers MUC1, keratin K19 and keratin K14 revealed
that the structures were indeed luminal and in addition
were correctly polarized (Fig. 4a, c’-d’). Moreover, it was
evident that the structures expanded much more on
CD105high/CD26low than on CD105low/CD26high fibro-
blasts (Fig. 4a). Quantitative image analysis revealed a
consistently higher level of branching morphogenesis on
lobular, CD105high/CD26low fibroblasts, compared to
interlobular, CD105low/CD26high fibroblasts in all combi-
nations of biopsies tested (Fig. 4b).
The relevance of the tissue of origin of CD105high cells
was further supported by the finding that CD105+
hMSCs did not support tubular structure formation.
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These experiments suggested that crude epithelial popula-
tions contain progenitors that are able to respond to a
relevant microenvironment upon appropriate stimulation.
This was confirmed by confronting purified epithelial pro-
genitors and differentiated epithelial cells, respectively [6],
with CD105low/CD26high and CD105high/CD26low fibro-
blasts. While differentiated epithelial cells remained as sin-
gle cells, purified progenitors proliferated and generated
correctly polarized structures (Additional file 5: Figure
S5). Taken together, these results are in strong favor of the
existence of two lineages of stromal cells in the human
breast, one of which has characteristics in common with
MSCs and provides a specialized microenvironment for
luminal progenitors in the TDLU.
Discussion and conclusions
Previous attempts to demonstrate stable fibroblast line-
ages from the normal human breast by serial passage have
been affected by phenotypic drifting of the isolated cells
[22]. Early-passage crudely isolated intralobular fibroblasts
were devoid of CD26 (DPPIV), but with passage they had
CD26 induced and became indistinguishable from inter-
lobular fibroblasts [22].
In the present study, intralobular fibroblasts are posi-
tively identified and isolated based on a high expression
of CD105, and we found that the CD105high/low pheno-
type is stably maintained with extended culture. We
therefore suggest that CD105 is a more reliable marker
for distinguishing intralobular and interlobular fibro-
blasts. Moreover, cellular and molecular analyses were
employed to establish whether the two populations iso-
lated in the present study indeed remain functionally dif-
ferent. We demonstrated that CD105high/CD26low lobular
fibroblasts and CD105low/CD26high interlobular fibroblasts
represent two distinct functionally specialized lineages.
Both lineages grow in culture and maintain their CD105/
CD26 phenotype. However, the CD105high/CD26low lobu-
lar fibroblasts are further distinguished by their capacity
to differentiate into adipogenic and osteogenic lineages.
Moreover, upon exposure to serum originally shown to re-
veal myofibroblastic differentiation in normal breast fibro-
blasts [18], the gene expression profile of CD105high/
CD26low cells partly overlaps with the profile of breast
tumor stroma. This might indicate that intralobular fibro-
blasts are more prone to generating myofibroblasts should
cancer arise in the TDLU - the predominant site of breast
tumor occurrence per se.
That functional heterogeneity within a tissue stromal
compartment may exist has been described by others.
Thus, in mouse skin, two subpopulations of fibroblasts
derived from a common fibroblast progenitor localize to
the upper and lower dermis, respectively [2]. Interest-
ingly, like the two fibroblast lineages described here, one
expresses CD26 and the other is capable of undergoing
adipogenic differentiation suggesting that these charac-
teristics may serve as more general markers of stromal
cell type stratification [2, 29]. Furthermore, heterogen-
eity amongst fibroblasts and distinct fibroblast features
has been implicated as a risk factor for developing breast
cancer. Of note, a more migratory fibroblast phenotype
has been detected in relatives of patients with hereditary
breast cancer [30] (reviewed in [31]), emphasizing that
more knowledge of the stromal compartment in general
may be relevant for the understanding of cancer
pathogenesis.
Several independent observations point towards luminal
progenitors as potential precursors of human breast can-
cer, somewhat surprisingly also including basal-like breast
cancer [32, 33]. This has put an enormous emphasis on
luminal cells in developing reliable assays for human
breast morphogenesis and homeostasis not least from the
point of view that the lifetime risk of developing cancer
correlates with the total number of divisions of long-lived
cells in a tissue [34]. The co-culture assay presented here
may prove suitable for such analyses. Specific populations
of epithelial cells isolated as single cells can be plated on
fibroblast feeders and the result of epithelial-stromal inter-
action can be monitored directly. The relevance of directly
(See figure on previous page.)
Fig. 3 CD105high fibroblasts exhibit a transforming growth factor (TGF)β profile and mesenchymal stem-like properties. a Heat map representation
of microarray analysis of 44 selected, differentially expressed genes in CD26high and CD105high fibroblasts (passage 9). Color key indicates centered
and row-scaled normalized intensity values. b Overlap between the top 302 median ranked significantly and differentially expressed genes and
previously published profiles of breast normal and tumor stroma, respectively. Bars indicate the number of overlapping genes in CD26high or
CD105high cells compared to tumor or normal stroma, respectively. The overlap between genes expressed by CD105high cells and tumor stroma
was statistically significant on analysis by Fisher’s exact test (p < 0.001). c Oil Red O staining of lipid droplets at day 15 of adipocyte differentiation in
CD26high and CD105high cells, respectively, with nuclei stained with hematoxylin. d RT-qPCR of osteoblast and adipocyte marker gene expression
(CCAAT/Enhancer binding protein, alpha (CEBPA), Collagen type 1 alpha 1 (Col1a1), and Runt-Related Transcription Factor 2 (Runx2)) in CD26high (light
bars) and CD105high (dark bars) cells at day 3 of differentiation in passage 11 presented as gene expression relative to the geometric mean of two
reference genes (UBC and B2m). The difference was statistically significant for CEBPA and Col1a1 in three different biopsies on analysis by unpaired
Student’s t test at p < 0.05. e Alizarin Red staining and quantification of the mineralized matrix at day 15 after exposure to osteogenic induction
medium (OIM, +) or control conditions without inducing factors (−). On analysis by unpaired Student’s t test the difference in Alizarin Red staining in
samples representing four biopsies, two in passage 11 and two in passage 13, was not statistically significant in CD26high with and without osteogenic
induction, but was significant at p < 0.05 in CD105high with and without induction (scale bar = 100 μm). Error bars represent mean +/− SD
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exposing luminal cells to stromal fibroblasts from which
they in situ are separated by myoepithelial cells and base-
ment membrane could be questioned. However, while lu-
minal cells at a glance may seem completely enveloped by
myoepithelial cells, higher magnifications reveal that they
project into the surrounding stroma containing delimiting
fibroblasts [35]. The interstitial stroma in turn forms a
barrier between capillaries and epithelium, across which
epitheliotrophic stimuli from the blood supply must pass
[36]. The details of how this signaling and how the com-
munication between epithelium and stromal cells across
the stroma takes place remain to be unraveled.
Our data nevertheless favor that luminal epithelial pro-
genitors receive input from the lobular stromal micro-
environment. Thus, they respond by clonal expansion
and branching morphogenesis, including the formation
of correctly polarized luminal epithelial cells. It cannot
be excluded that the effect of intralobular fibroblasts
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Fig. 4 CD105high stroma is a specialized microenvironment for branching morphogenesis of luminal breast epithelial cells. a Primary cultures of
purified luminal breast epithelial cells plated at clonal density on confluent feeders of CD26high (left column) or CD105high (right column) fibroblasts: phase
contrast micrographs of co-cultures twenty days after plating showing branching morphogenesis primarily on CD105high fibroblasts (a’, b’); dual-color
imaging of co-cultures stained with keratin K19 (red) and MUC1 (green). Note the correctly polarized staining pattern and the elaborate structures on
CD105high fibroblasts (c’, d’); low-magnification micrographs of co-cultures ten days after plating and immunoperoxidase staining for keratin K19 (e’, f’);
digitalized images of keratin K19-stained epithelial structures (g’, h’). b Quantitative representation of K19-stained morphological structures in multiple
recombinant cultures representing eight biopsies showing consistent growth advantage of luminal epithelial cells on CD105high fibroblasts (red bars) as
normalized in each set of samples to structures formed on CD26high fibroblasts (blue bars) (scale bar= 50 μm (a’, b’); 100 μm (c’, d’); 500 μm (e’-h’))
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reported here in the adult breast may reflect a similar
function in early development. In the infant breast, fibro-
blasts surrounding developing epithelial structures are de-
void of CD26 (DPPIV) and thus, distinct from interlobular
CD26 (DPPIV)-positive fibroblasts [37]. We further dem-
onstrate that morphogenesis can occur independently of
the presence of myoepithelial cells. Interestingly, in vivo
where stroma is amply present, lineage tracing in the
mouse mammary gland shows that the luminal epithelial
compartment expands exclusively by self-duplication [38].
By contrast, in culture deprived of stroma, luminal epithe-
lial cells apparently become multipotent, and those from
mice in addition acquire mammary repopulating capability
[10, 39, 40]. Thus, the present approach mimics the lobu-
lar epithelial microenvironment and unravels the activity
of luminal epithelial progenitors. This finding may pave
the way for further interrogation of developmental pro-
cesses reflecting epithelial-stromal crosstalk in the normal
human breast as well as in breast cancer.
Additional files
Additional file 1: Figure S1. Confirmation of microarray analysis by RT-
qPCR. RT-qPCR of a representative subset of differentially expressed genes
between CD105high and CD26high fibroblasts presented as the relative
normalized expression level in CD105high to CD26high fibroblasts. The
genes analyzed include signal peptide, CUB domain and EGF like domain
containing 3 (SCUBE3), CD105/endoglin (ENG), growth differentiation factor
6 (GDF6), collagen type XI alpha 1 chain (COL11A1), tetraspanin 2 (TSPAN2),
collagen type IV alpha 1 chain (COL4A1), actin, alpha 2, smooth muscle, aorta
(ACTA2), tenascin C (TNC), activin A receptor like type 1 (ACVRL1), collagen
type XV alpha 1 chain (COL15A1), calponin 1 (CNN1), dermatopontin (DPT),
fibronectin type III domain containing 1 (FNDC1), activin A receptor type 2A
(ACVR2A), laminin subunit alpha 2 (LAMA2), interleukin 1 receptor like 1
(IL1RL1), interleukin 33 (IL33), hepatocyte growth factor (HGF), complement
factor B (CFB); G protein-coupled receptor class C group 5 member B
(GPRC5B), complement component 3 (C3) and decorin (DCN). Error bars
represent mean +/− SD. (PDF 34 kb)
Additional file 2: Figure S2. Co-expression of CD105 and α-smooth
muscle actin in CD105high fibroblasts. Upon serum starvation and subsequent
stimulation with 20 % serum, α-smooth muscle actin is further induced in
CD105-expressing cells. Highly smooth muscle- differentiated cells tend to
exhibit lower CD105 expression (scale bar= 50 μm). (PDF 1786 kb)
Additional file 3: Figure S3. CD105high and CD26high fibroblasts remain
phenotypically and functionally different in high passage cultures. a Alkaline
phosphatase (ALP) activity, an early marker of osteoblast differentiation, in
osteogenic induced cultures (light bars) versus non-induced cultures (dark
bars) of CD26high and CD105high cells, analyzed at day 6 after induction of
three different biopsies (one in passage 9 and two in passage 10). The
difference in ALP activity was significant on analysis by unpaired Student’s t
test in induced versus non-induced CD105high cells only (p < 0.0001). Error
bars represent mean +/− SD. b ALP activity in osteogenic induced (light
bars) versus non-induced (dark bars) cultures of CD26high and CD105high
cells, analyzed at day 6 in passage 10 and 15, respectively, after initial sorting
in passage 5. Data represent quadruplicate samples from two biopsies and are
presented as arbitrary units (ARBU). CD105high cells maintain their osteogenic
differentiation capacity up to passage 15 indicating that their distinct
functional properties are maintained in higher passages. Error bars represent
mean +/− SD. (PDF 33 kb)
Additional file 4: Figure S4. Gating strategy to isolate uncultured
primary breast MUC1high epithelial cells by FACS. Uncultured primary
breast cells from trypsinized organoids were incubated with antibodies
against CD271, a marker of myoepithelial cells, and MUC1, a marker of
luminal epithelial cells, and analyzed by FACS. The MUC1high cells were
selected and isolated as indicated. (PDF 30 kb)
Additional file 5: Figure S5. Branching morphogenesis reflects activity
of luminal progenitors. Primary cultures of purified luminal breast
epithelial cells plated at clonal density on confluent feeders of (left
column) CD26high or (right column) CD105high fibroblasts stained for
MUC1 by immunoperoxidase. Nuclear counterstain is omitted to clearly
outline epithelial cells. EpCAMhigh/CD166high/67LRhigh differentiated
luminal epithelial cells (CD166high/67LRhigh) remained as single cells upon
confrontation with fibroblast feeders (upper panel), while EpCAMhigh/
CD166low/67LRlow progenitors (CD166low/67LRlow) responded by
undergoing branching morphogenesis with larger structures forming on
CD105high fibroblasts (lower panel) (scale bar = 100 μm). (PDF 9484 kb)
Abbreviations
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